News and Press Releases

Check out our latest news.

All
News · Kira Pharmaceuticals

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference

Oral presentation characterizes promising PK/PD properties of KP104 in relevant animal models and supports its further development as a potent bifunctional complement inhibitor suitable for both intravenous and subcutaneous administration... Read more
Aug 26, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (August 1, 2022) – Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the... Read more
Aug 01, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (July 28, 2022) – Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that... Read more
Jul 28, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Appoints Teri Loxam as Chief Operating Officer and Chief Financial Officer

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (November 16, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement-targeted therapies to treat immune-mediated diseases, today announced the... Read more
Nov 12, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (February 23, 2021)CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (February 23, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted... Read more
Feb 22, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine

CAMBRIDGE, MA and SUZHOU, JIANGSU (February 2, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, announced today that the first... Read more
Feb 01, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference

Oral presentation characterizes promising PK/PD properties of KP104 in relevant animal models and supports its further development as a potent bifunctional complement inhibitor suitable for both intravenous and subcutaneous administration... Read more
Aug 26, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (August 1, 2022) – Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the... Read more
Aug 01, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (July 28, 2022) – Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that... Read more
Jul 28, 2022
News · Kira Pharmaceuticals

Kira Pharmaceuticals Appoints Teri Loxam as Chief Operating Officer and Chief Financial Officer

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (November 16, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement-targeted therapies to treat immune-mediated diseases, today announced the... Read more
Nov 12, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China

CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (February 23, 2021)CAMBRIDGE, MA, USA and SUZHOU, JIANGSU, CHINA (February 23, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted... Read more
Feb 22, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine

CAMBRIDGE, MA and SUZHOU, JIANGSU (February 2, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, announced today that the first... Read more
Feb 01, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA and SUZHOU, China (January 12, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced that Frederick... Read more
Jan 12, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies

CAMBRIDGE, MA and SUZHOU, China (January 7, 2021) – Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of... Read more
Jan 07, 2021
News · Kira Pharmaceuticals

Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases

– $46M in Financing Secured from Leading Global Life Science Investors – Frederick Beddingfield Appointed as CEO CAMBRIDGE, MA and SUZHOU, China (November 12, 2020) – Kira Pharmaceuticals, a global biotechnology company pioneering a new... Read more
Nov 11, 2020

Get in touch with us!

Get in touch to learn more about our LOGIC discovery platform and pipeline.